These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4147193)

  • 21. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol].
    Gries J; Unger L; Einig H; Friedrich L; Hofmann HP; Kreiskott H; Lehmann HD; von Philipsborn G; Wuppermann D; Zimmermann F
    Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
    Bartsch W; Sponer G; Dietmann K
    Arzneimittelforschung; 1977; 27(12):2319-22. PubMed ID: 23798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of beta-adrenoceptors in the guinea pig.
    Bertholet A; Milavec M; Waite R
    Postgrad Med J; 1981; 57 Suppl 1():9-17. PubMed ID: 6272256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
    Bilski A; Wale J; Dawes PM
    Br J Pharmacol; 1976 Mar; 56(3):362P. PubMed ID: 4182
    [No Abstract]   [Full Text] [Related]  

  • 28. beta-blockade, atrial natriuretic peptide and exercise.
    Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats.
    Bartsch W; Sponer G; Dietmann K; Kohler M
    Arzneimittelforschung; 1981; 31(11):1885-8. PubMed ID: 6119093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH
    Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.
    Boakes AJ; Prichard BN
    Br J Pharmacol; 1973 Mar; 47(3):673P-674P. PubMed ID: 4147197
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological characterisation of -receptor blocking agents.
    Saameli K
    Jpn J Pharmacol; 1972; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract]   [Full Text] [Related]  

  • 34. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 35. Duration of action and plasma levels of beta-adrenoceptor blocking drugs.
    Aellig WH
    Arch Int Pharmacodyn Ther; 1980; Suppl():32-7. PubMed ID: 6106456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D; Singleton W; Silke B; Taylor SH
    Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
    Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
    Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.